Nobivac®

Canine Flu H3N2

The first fully licensed vaccine for dogs and cats to protect against canine influenza H3N2 infections.

PROVIDING PROTECTION AGAINST H3N2

Nobivac® Canine Flu H3N2 (Inactived virus).

  • Reduced the incidence and severity of coughing1
  • Decreased the overall clinical signs of disease, including ocular and nasal discharge, coughing, sneezing, depression, and dyspnea1
  • Demonstrated protection against the formation and severity of lung lesions1
  • Contains inactivated virus; adjuvanted to enhance immune response
  • For Cats:
    • Induces high antibody response to vaccination
    • Protected against pneumonia
    • Significantly reduced lung consolidation compared to control cats

Indications:

This product has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older or healthy cats 10 weeks of age or older against canine influenza virus.

CANINE INFLUENZA VACCINE H3N2 IS A SAFE CHOICE FOR DOGS AND CATS

  • Well tolerated on subcutaneous administration
  • Proven safe across a multitude of breeds and ages

ADMINISTRATION AND DOSAGE

  • 1 mL subcutaneous injection
  • Booster two to four weeks later
  • Annual revaccination with one dose is recommended
  • Available in a 25 x 1 mL dose presentation

ALSO AVAILABLE IN OTHER FORMULATIONS

DISEASE INFORMATION

Professional Resources and Educational Materials

Keep your clinic and staff informed and aware of diseases and outbreaks.

AAHA Canine Vaccination Guidelines

In-depth information about canine vaccinations and veterinary best practices.

Download

Addressing CIV in Your Clinic

eBook

Tips and guidelines for your clinic to prevent and manage canine influenza.

Learn More

Nobivac® Social Media Kits

Digital Assets

Use these ready-to-share posts to educate pet parents and drive business to your clinic for preventative care.

Download

No items to show.

Loading…

References:

1. Data on file, Merck Animal Health.

View All Nobivac References